Citadel Advisors’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-74,505
Closed -$3.5M 14307
2025
Q2
$3.5M Sell
74,505
-177,009
-70% -$7.87M ﹤0.01% 4707
2025
Q1
$11.1M Sell
251,514
-121,717
-33% -$5.6M 0.01% 2712
2024
Q4
$13.5M Buy
373,231
+242,525
+186% +$8.47M 0.01% 2598
2024
Q3
$4.19M Buy
130,706
+32,755
+33% +$1.22M ﹤0.01% 4238
2024
Q2
$3.69M Sell
97,951
-612,316
-86% -$25.8M ﹤0.01% 4239
2024
Q1
$35M Buy
710,267
+292,453
+70% +$13.5M 0.03% 1509
2023
Q4
$15.3M Buy
417,814
+396,508
+1,861% +$10.3M 0.02% 2316
2023
Q3
$493K Buy
21,306
+13,225
+164% +$362K ﹤0.01% 8091
2023
Q2
$212K Sell
8,081
-25,872
-76% -$680K ﹤0.01% 9748
2023
Q1
$874K Sell
33,953
-92,993
-73% -$2.72M ﹤0.01% 7089
2022
Q4
$3.3M Sell
126,946
-40,049
-24% -$987K ﹤0.01% 4587
2022
Q3
$4.76M Buy
166,995
+37,580
+29% +$1.08M 0.01% 3952
2022
Q2
$3.19M Buy
129,415
+102,516
+381% +$3.75M ﹤0.01% 4652
2022
Q1
$1.52M Sell
26,899
-27,283
-50% -$1.56M ﹤0.01% 6707
2021
Q4
$3.36M Sell
54,182
-117,954
-69% -$7.81M ﹤0.01% 5119
2021
Q3
$10.9M Sell
172,136
-639,889
-79% -$49.3M 0.01% 2932
2021
Q2
$66.9M Buy
812,025
+10,634
+1% +$807K 0.07% 915
2021
Q1
$59M Buy
801,391
+8,605
+1% +$674K 0.06% 914
2020
Q4
$57.5M Buy
792,786
+34,207
+5% +$2.2M 0.06% 851
2020
Q3
$36.2M Sell
758,579
-166,102
-18% -$7.07M 0.05% 1077
2020
Q2
$38.8M Sell
924,681
-18,614
-2% -$662K 0.05% 964
2020
Q1
$25.5M Buy
943,295
+12,426
+1% +$405K 0.04% 1050
2019
Q4
$35.8M Sell
930,869
-392,948
-30% -$9.2M 0.04% 993
2019
Q3
$28.7M Buy
+1,323,817
New +$31.3M 0.04% 1163

Other funds holding SWTX